138 related articles for article (PubMed ID: 11071654)
21. Enhancement of differentiation induction and upregulation of CCAAT/enhancer-binding proteins and PU.1 in NB4 cells treated with combination of ATRA and valproic acid.
Iriyama N; Yuan B; Yoshino Y; Hatta Y; Horikoshi A; Aizawa S; Takei M; Takeuchi J; Takagi N; Toyoda H
Int J Oncol; 2014 Mar; 44(3):865-73. PubMed ID: 24379003
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of caffeic acid phenethyl ester on all-trans retinoic acid-induced differentiation in human leukemia HL-60 cells.
Kuo HC; Kuo WH; Lee YJ; Wang CJ; Tseng TH
Toxicol Appl Pharmacol; 2006 Oct; 216(1):80-8. PubMed ID: 16766008
[TBL] [Abstract][Full Text] [Related]
23. Phosphodiesterase IV inhibition by piclamilast potentiates the cytodifferentiating action of retinoids in myeloid leukemia cells. Cross-talk between the cAMP and the retinoic acid signaling pathways.
Parrella E; Gianni' M; Cecconi V; Nigro E; Barzago MM; Rambaldi A; Rochette-Egly C; Terao M; Garattini E
J Biol Chem; 2004 Oct; 279(40):42026-40. PubMed ID: 15292163
[TBL] [Abstract][Full Text] [Related]
24. Laminin promotes differentiation of NB4 promyelocytic leukemia cells with all-trans retinoic acid.
Becker PS; Li Z; Potselueva T; Madri JA; Newburger PE; Berliner N
Blood; 1996 Jul; 88(1):261-7. PubMed ID: 8704182
[TBL] [Abstract][Full Text] [Related]
25. Induction of differentiation in acute promyelocytic leukemia cells by 9-cis retinoic acid alpha-tocopherol ester (9-cis tretinoin tocoferil).
Makishima M; Umesono K; Shudo K; Naoe T; Kishi K; Honma Y
Blood; 1998 Jun; 91(12):4715-26. PubMed ID: 9616170
[TBL] [Abstract][Full Text] [Related]
26. AM580, a stable benzoic derivative of retinoic acid, has powerful and selective cyto-differentiating effects on acute promyelocytic leukemia cells.
Gianní M; Li Calzi M; Terao M; Guiso G; Caccia S; Barbui T; Rambaldi A; Garattini E
Blood; 1996 Feb; 87(4):1520-31. PubMed ID: 8608243
[TBL] [Abstract][Full Text] [Related]
27. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
[TBL] [Abstract][Full Text] [Related]
28. All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL).
Orfali N; O'Donovan TR; Cahill MR; Benjamin D; Nanus DM; McKenna SL; Gudas LJ; Mongan NP
Eur J Haematol; 2020 Mar; 104(3):236-250. PubMed ID: 31811682
[TBL] [Abstract][Full Text] [Related]
29. Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor.
Komura N; Ikeda Y; Masuda N; Umezawa Y; Ito K; Kizaki M; Umezawa K
Leuk Res; 2007 Mar; 31(3):301-13. PubMed ID: 16968653
[TBL] [Abstract][Full Text] [Related]
30. all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia.
Ozpolat B; Mehta K; Tari AM; Lopez-Berestein G
Am J Hematol; 2002 May; 70(1):39-47. PubMed ID: 11994980
[TBL] [Abstract][Full Text] [Related]
31. Stress-induced NF-κB activation differentiates promyelocytic leukemia cells to macrophages in response to all-trans-retinoic acid.
Imran M; Park JS; Lim IK
Cell Signal; 2015 Mar; 27(3):694-706. PubMed ID: 25435432
[TBL] [Abstract][Full Text] [Related]
32. WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potential.
Laurenzana A; Cellai C; Vannucchi AM; Pancrazzi A; Romanelli MN; Paoletti F
Leukemia; 2005 Mar; 19(3):390-5. PubMed ID: 15674364
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of sensitivity by bestatin of acute promyelocytic leukemia NB4 cells to all-trans retinoic acid.
Hirano T; Kizaki M; Kato K; Abe F; Masuda N; Umezawa K
Leuk Res; 2002 Dec; 26(12):1097-103. PubMed ID: 12443882
[TBL] [Abstract][Full Text] [Related]
34. Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells.
Chen Z; Wang W; Pan J; Chen L; Xue Y
Chin Med J (Engl); 1999 Apr; 112(4):352-5. PubMed ID: 11593538
[TBL] [Abstract][Full Text] [Related]
35. Effects of novel retinoic acid compound, 9-cis-retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor-alpha and retinoid X receptor-alpha RNA by HL-60 cells.
Kizaki M; Ikeda Y; Tanosaki R; Nakajima H; Morikawa M; Sakashita A; Koeffler HP
Blood; 1993 Dec; 82(12):3592-9. PubMed ID: 8260698
[TBL] [Abstract][Full Text] [Related]
36. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.
Xi ZF; Russell M; Woodward S; Thompson F; Wagner L; Taetle R
Leukemia; 1997 Feb; 11(2):212-20. PubMed ID: 9009083
[TBL] [Abstract][Full Text] [Related]
37. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.
Gruber A; Berlit J; Speth C; Lass-Flörl C; Kofler G; Nagl M; Borg-von Zepelin M; Dierich MP; Würzner R
Immunobiology; 1999 Sep; 201(1):133-44. PubMed ID: 10532286
[TBL] [Abstract][Full Text] [Related]
38. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
39. All-trans retinoic acid reverses phorbol ester resistance in a human myeloid leukemia cell line.
Yang KD; Mizobuchi T; Kharbanda SM; Datta R; Huberman E; Kufe DW; Stone RM
Blood; 1994 Jan; 83(2):490-6. PubMed ID: 8286746
[TBL] [Abstract][Full Text] [Related]
40. Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system.
Zhang L; Gorset W; Washington CB; Blaschke TF; Kroetz DL; Giacomini KM
Drug Metab Dispos; 2000 Mar; 28(3):329-34. PubMed ID: 10681378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
